CAMGENE THERAPEUTICS LIMITED
CopyKey Data
Status
Company No.
Incorporation date
Size
Contacts
Registered address
Total Assets
No recordsNumber of employees
No recordsCash in Bank
No recordsConfirmation
Accounts
Financial Ratios
No financial ratios available
This company has not submitted financial statements or the data is not publicly available. Please check back later – the information may be updated.
People
Officers
Persons with Significant Control
Similar companies
Category:
Post-harvest crop activitiesComp. code:
03185729Reg. date:
15/04/1996Turnover:
-No. of employees:
-Category:
Silviculture and other forestry activitiesComp. code:
12543378Reg. date:
01/04/2020Turnover:
-No. of employees:
-Category:
Mixed farmingComp. code:
SC127217Reg. date:
12/09/1990Turnover:
-No. of employees:
-Category:
Growing of other non-perennial cropsComp. code:
SC278017Reg. date:
06/01/2005Turnover:
-No. of employees:
-Category:
Mixed farmingComp. code:
02153348Reg. date:
07/08/1987Turnover:
-No. of employees:
-Description
About CAMGENE THERAPEUTICS LIMITED
CAMGENE THERAPEUTICS LIMITED is an(a) Active company incorporated on 07/06/2023 with the registered office located at Hauxton House Mill Scitech Park Mill Lane, Hauxton, Cambridge CB22 5HX. There are currently 7 active directors according to the latest confirmation statement. Number of employees Unknown according to last financial statements.Frequently Asked Questions
What is the current status of CAMGENE THERAPEUTICS LIMITED?
CAMGENE THERAPEUTICS LIMITED is currently Active. It was registered on 07/06/2023 .
Where is CAMGENE THERAPEUTICS LIMITED located?
CAMGENE THERAPEUTICS LIMITED is registered at Hauxton House Mill Scitech Park Mill Lane, Hauxton, Cambridge CB22 5HX.
What does CAMGENE THERAPEUTICS LIMITED do?
CAMGENE THERAPEUTICS LIMITED operates in the Research and experimental development on biotechnology (72.11 - SIC 2007) sector.
What is the latest filing for CAMGENE THERAPEUTICS LIMITED?
The latest filing was on 17/05/2026: Statement of capital following an allotment of shares on 2026-05-13.